(NASDAQ:IRD), Outcome of Regenerative Medicine Advanced Therapy (RMAT) meeting provides the potential for an accelerated regulatory pathway to approval of OPGx-LCA5 First participant enrolled in run-in period for planned adaptive Phase 3 trial Company intends to apply for the FDA's new Rare Disease Evidence Principles (RDEP) review process OPGx-LCA5 has the potential to be the […]

(CNSX:MAXX),(CNSX:MAXX.CN),(Pinksheets:MAXXF),(PinkSheets:MAXXF),(Boerse Frankfurt – Freiverkehr:89N.F),(Boerse Frankfurt – Freiverkehr:89N), Saskatchewan Energy Leader Tom Kishchuk, Executive Director of the Global Institute for Energy, Minerals and Society, Joins MAX Power Board as Canada's First-Ever Natural Hydrogen Drill Program Gets Set To Begin MAX Power Saskatchewan Natural Hydrogen Documentary Videohttps://www.maxpowermining.com/NaturalHydrogen-NewEra/ SASKATOON, Saskatchewan, Nov. 06, 2025 (GLOBE NEWSWIRE) — MAX Power

(NasdaqGM:RAPP), Positive topline results announced from Phase 2a clinical trial of RAP-219 in patients with focal onset seizures Phase 2 trial of RAP-219 in bipolar mania enrolling patients and on track, with topline results expected in the first half of 2027 Strong balance sheet, bolstered by approximately $269.4 million in net proceeds from recent public

(NYSE Arca:BLOK),(CBOE:BITY),(CBOE:BAGY),(CBOE:ETTY),(CBOE:EHY),(NYSE Arca:SOLM), CHICAGO, Nov. 06, 2025 (GLOBE NEWSWIRE) — Amplify ETFs, a leading provider of breakthrough ETF solutions, has been named Best Crypto-Linked ETF Issuer ($100 million-$1 billion) by ETF Express, recognizing the firm's pioneering role and continued contributions in the evolving digital assets ETF landscape. As of Nov. 4, 2025, Amplify has six

(NasdaqGM:MAZE), SOUTH SAN FRANCISCO, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) — Maze Therapeutics, Inc. (Nasdaq: MAZE), a clinical-stage biopharmaceutical company developing small molecule precision medicines for patients with kidney and metabolic diseases, today announced seven presentations at the American Society of Nephrology's (ASN) Kidney Week, being held November 6-9 in Houston, Texas. During the meetings,

(NASDAQ:ATXI),(OTC US:ATXI),(OtherOTC:ATXI),(NASDAQ:FBIO),(NasdaqGM:AXSM), MIAMI, Nov. 06, 2025 (GLOBE NEWSWIRE) — Avenue Therapeutics, Inc. (OTC: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic diseases, and its majority-owned subsidiary, Baergic Bio, Inc. (“Baergic”), today announced that Avenue has entered into an agreement for Baergic

(NasdaqGM:LGND), Third quarter performance driven by strong portfolio royalty revenue growth of 47% 2025 full year revenue guidance increased to $225 million – $235 million (previously $200 million – $225 million) and adjusted earnings per diluted share1 increased to $7.40 – $7.65 (previously $6.70 – $7.00) Conference call begins at 8:30 a.m. Eastern Time today

(NasdaqGM:CMRC), AUSTIN, Texas, Nov. 06, 2025 (GLOBE NEWSWIRE) — Commerce.com, Inc. (Nasdaq: CMRC) (formerly BigCommerce Holdings, Inc.), a provider of an open, intelligent ecosystem of technology solutions that empower businesses to unlock data potential and deliver seamless, personalized experiences at scale, today announced financial results for its third quarter ended September 30, 2025. “The third

AUSTIN, Texas, Nov. 06, 2025 (GLOBE NEWSWIRE) — Vetty, the one-stop shop hiring acceleration platform, shared today that CEO Jason Putnam has won the 2025 Inspiring Leaders Award from the Inspiring Workplaces Group (IWG). This is Putnam's second consecutive win, recognized in 2024 for his work as CRO of Plum. Produced in partnership with RADICL,

(TSX:SXP), MONTREAL, Nov. 06, 2025 (GLOBE NEWSWIRE) — Supremex Inc. (“Supremex” or the “Company”) (TSX: SXP), a leading North American manufacturer and marketer of envelopes and a growing provider of paper-based packaging solutions, today announced its results for the third quarter ended September 30, 2025. The Company will hold a conference call to discuss these